prof. MUDr. Jan Krejčí, Ph.D.
Department head, First Department of Internal Medicine - Cardioangiology
Total number of publications: 268
2025
-
Anabolic steroid abuse as a significant risk factor for cardiovascular morbidity
MEDICÍNA PRO PRAXI, year: 2025, volume: 22, edition: 5, DOI
-
Comparison of left ventricular function recovery in diabetic and non-diabetic patients with RODCM
Year: 2025, type: Appeared in Conference without Proceedings
-
Endocardial radiofrequency ablation of septal hypertrophy in the interventional treatment of the hypertrophic obstructive cardiomyopathy; comparison with the alcohol septal ablation, pilot data of the randomized trial
COR ET VASA, year: 2025, volume: 67, edition: 5, DOI
-
Global Registries and Surveys Programme-Heart Failure (GRASP-HF): Rationale, study design and research implications
European Journal of heart Failure, year: 2025, volume: 27, edition: 11, DOI
-
Nové trendy v diagnostice a léčbě hypertrofické kardiomyopatie
VNITŘNÍ LÉKAŘSTVÍ, year: 2025
-
Optimizing beta-blocker therapy in chronic heart failure: a real-world study of patients with and without atrial fibrillation
POSTGRADUATE MEDICINE, year: 2025, volume: 137, edition: 8, DOI
-
PO-04-037 A PROSPECTIVE RANDOMIZED CLINICAL COMPARISON OF CATHETER ABLATION OF ATRIAL FIBRILLATION USING THE CENTAURI PEF SYSTEM, FARAPULSE SYSTEM, AND STANDARD RADIOFREQUENCY CATHETER ABLATION
Year: 2025, type: Conference abstract, DOI
-
PROGNOSTICKÉ IMPLIKACE INTOLERANCE ZÁTĚŽE NA DLOUHODOBÝ OUTCOME PACIENTŮ PO IZOLACI PLICNÍCH ŽIL PRO PAROXYSMÁLNÍ FIBRILACI SÍNÍ
Year: 2025, type: Conference abstract
-
RANDOMIZOVANÉ SROVNÁNÍ KATÉTROVÉ ABLACE FIBRILACE SÍNÍ STANDARDNÍM PŘÍSTUPEM POMOCÍ PULSE FIELD ENERGY SYSTÉMU CENTAURI A KONVENČNÍ RADIOFREKVENČNÍ ABLACE
Year: 2025, type: Conference abstract
-
Rare rhythm disorder in patients with hypertrophic obstructive cardiomyopathy during endocardial radiofrequency ablation of septal hypertrophy
Cor et Vasa, year: 2025, volume: 67, edition: 1, DOI